Welcome Back
Click “Sign in” to agree to Cointime’s Terms of Service and acknowledge that Cointime’s Privacy Policy applies to you.
Join CoinTime
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">Terms of Service</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">Privacy Policy</a> applies to you.
Sign in with email
Sign up with email
Your email
Check your inbox
Click the link we sent to to sign in.
Click the link we sent to to sign up.
Laurent Pharmaceuticals
company
About
Laurent Pharmaceuticals is a private biopharmaceutical company developing a clinical stage, orally-active drug candidate.
- 1 - 10
Highlights
Details
- Last Funding Type
- Series Unknown
- Industries
- Biotechnology,Health Care,Pharmaceutical
- Founded date
- Jan 1, 2012
- Number Of Employee
- 1 - 10
- Operating Status
- Active
Laurent Pharmaceuticals is a private biopharmaceutical company developing a clinical-stage, orally-active drug candidate. The company has a clinical-stage drug development program (LAU-7b) that addresses the compromised immune-inflammatory response in Cystic Fibrosis (CF), a critical but still enigmatic pathogenic pathway leading to pulmonary insufficiency in CF patients.Laurent Pharmaceuticals was founded in 2012 and is headquartered in Montréal, Quebec.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
—
Laurent Pharmaceuticals has raised a total of
—
in funding over 2 rounds. Their latest funding was raised on
Oct 25, 2018 from a Series Unknown round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Oct 25, 2018 | Series Unknown | — | 1 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
1
Laurent Pharmaceuticals is funded by 1 investors.
Keiretsu Forum Mid Atlantic
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
Keiretsu Forum Mid Atlantic
|
— | Series Unknown |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
